6.900
−1,43%
2026-08-07
Fundamental Analysis
44 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -26.0% | +42.3% | 2 / 3 | -29.6% | +9.02 pp | -6.48 pp | — | -0.98 | — | 9,3 | −29,6% | −1,4 | −26,0% | — | -9.68 | — |
| Pts | 0 | 8 | 8 | 0 | 12 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 6.900 (close price on 2026-08-07)EPS (TTM): −105,5
Financial charts
1.Revenue & growth
VND bn9,34Q2/26
1.Revenue & growth
VND bn9,34Q2/26
2.Profit & growth
VND bn-1,37Q2/26
3.Profit mix (Penman)
VND bn-3,17Q2/26
4.Margins & cost structure
%18.0%Q2/26
5.Returns & cash cycle
% · days-408%Q2/26
6.Earnings quality & cash
VND bn0,87Q2/26
7.Asset structure
VND bn95,4Q2/26
8.Funding & debt health
VND bn · times95,4Q2/26
9.Revenue backlog
VND bn8,31Q2/26
10.Valuation
times · %-65,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-46Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26